2021年12月9日 · The applicable sections on revascularization from the 2012 stable ischemic heart disease (SIHD) guideline, 4 as well as the 2013 ST-segment–elevation myocardial infarction (STEMI) 5 and 2014 non–ST-segment–elevation myocardial infarction (NSTEMI) guidelines, 6 will also be updated. This present guideline will affect the following documents:

2014年9月23日 · The 2014 NSTE-ACS CPG is a full revision of the 2007 ACCF/AHA CPG for the management of patients with unstable angina (UA) and non-ST-elevation myocardial infarction (NSTEMI) and the 2012 focused update. 8 The new title, “Non-ST-Elevation Acute Coronary Syndromes,” emphasizes the continuum between UA and NSTEMI. At presentation, patients ...

2023年8月25日 · This guideline provides a comprehensive overview of the management of patients presenting with Acute coronary syndrome (ACS) from the point of diagnosis and risk stratification at initial presentation, through to long-term management after the initial hospitalisation period.

2021年5月20日 · Early routine invasive strategy is recommended for non-ST-segment elevation myocardial infarction (NSTEMI) determined by high-sensitivity cardiac troponin (hs-cTn) measurements, a GRACE risk score >140, and dynamic new ST-segment changes. Radial access is preferred.

2021年4月27日 · In patients with suspected non–ST-segment elevation acute coronary syndrome (NSTE-ACS), a 0-hour/1-hour high-sensitivity cardiac troponin assay algorithm is recommended to decrease time to clinical decision making while providing high sensitivity and diagnostic accuracy (class I, level B).

2023年8月29日 · The new ESC ACS guidelines combine previously separate guidelines for ST-elevation myocardial infarction (STEMI) and non-ST-elevation myocardial infarction (NSTEMI).

The MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non–ST-Elevation Acute Coronary Syndromes-Thrombosis In Myocardial Infarction) 36 trial examined the efficacy and safety of ranolazine in 6,560 patients with NSTE-ACS who presented within 48 hours of ischemic symptoms .

suspected acute coronary syndromes (ACS) is chest pain. Based on the electrocardiogram (ECG), two groups of patients should be differentiated: ∗ Acute ST segment elevation MI (STEMI) ∗ Non-ST segment elevation myocardial infarction (NSTEMI) • The pathological correlate at the myocardial level is cardiomyocyte necrosis -NSTEMI

2020年8月30日 · To lower the risk of major adverse events, the 2020 guidelines recommend an early routine invasive approach within 24 h for any of the following high-risk criteria: non-ST-segment elevation myocardial infarction (NSTEMI) based on hs-cTn measurements, GRACE risk score >140, and dynamic or presumably new contiguous ST/T-segment changes suggesting ...

Pocket Guidelines on Acute Coronary Syndromes (ACS) Publication Date: 2023. Chairpersons: Robert Byrne and Borja Ibanez. Order Pocket Guidelines. Table of Contents. 1. Introduction. 1.1. Definitions acute coronary syndromes and myocardial infarction. 2. Triage and diagnosis. 2.1. Clinical presentation and physical examination. 2.2.